Profil
Peter L.
Saltonstall is currently a Director at Trio Health Advisory Group, Inc. and a Director at Medical Device Innovation Consortium.
He was previously the President, Chief Executive Officer & Director at The National Organization for Rare Disorders, Inc.
Postes actifs de Peter L. Saltonstall
| Sociétés | Poste | Début |
|---|---|---|
Medical Device Innovation Consortium
Medical Device Innovation Consortium Miscellaneous Commercial ServicesCommercial Services Operates as trade association for processing, improving and advancing medical technologies | Directeur/Membre du Conseil | 01/02/2016 |
Trio Health Advisory Group, Inc.
Trio Health Advisory Group, Inc. Packaged SoftwareTechnology Services Develops proprietary technology platform | Directeur/Membre du Conseil | - |
Anciens postes connus de Peter L. Saltonstall
| Sociétés | Poste | Fin |
|---|---|---|
The National Organization for Rare Disorders, Inc.
The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services Provides medical funding and healthcare services | Directeur Général | 01/05/2024 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Trio Health Advisory Group, Inc.
Trio Health Advisory Group, Inc. Packaged SoftwareTechnology Services Develops proprietary technology platform | Technology Services |
The National Organization for Rare Disorders, Inc.
The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services Provides medical funding and healthcare services | Health Services |
Medical Device Innovation Consortium
Medical Device Innovation Consortium Miscellaneous Commercial ServicesCommercial Services Operates as trade association for processing, improving and advancing medical technologies | Commercial Services |
















